Xarelto (Generic Name: Rivaroxaban), is an anticoagulant designed for the prevention of blood clots after knee or hip replacement surgery, or due to atrial fibrillation (irregular heartbeat). The blood thinner is also used for the treatment of existing blood clots (ex. pulmonary embolus or deep vein thrombosis). Xarelto works by blocking proteins contained in the blood so they cannot form clots.
Xarelto was developed by Bayer and Jannsen Pharmaceuticals (A unit of Johnson & Johnson based in New Jersey). The Food and Drug Administration approved Xarelto following a fast-track regulatory process for the general treatment of pulmonary embolism and deep vein thrombosis which occur in patients after a hip replacement or knee replacement surgery. Unlike most other blood thinners that require a doctor to prescribe patient specific doses, this new breed of oral medication is now being prescribed in a uniform dose. In addition, unlike most other blood thinners on the market, Xarelto has no known antidote.
Prescribing medicine such as Xarelto in a uniform dose means patients do not have to under blood tests to determine the appropriate dosage. This makes Xarelto easier to prescribe than other anticoagulants on the markets, such as warfarin. Due to this marketing gift, Bayer made 1.3 billion in 2013 from Xarelto sales and is set to make increasing profits over the years to come.
Side Effects and Injuries of Xarelto
One of the most serious side effects of this new breed of anticoagulant is uncontrolled bleeding. If uncontrolled bleeding occurs near other major organs like the lungs, brain or kidneys, it interrupts the normal blood flow to these organs, resulting in a loss of functionality. These internal pools of blood pose numerous health risks. In addition, the nature of Xarelto as a blood thinner that prevents clotting of the blood to stop bleeding, magnifies the damage caused by uncontrolled bleeding from minor injuries.
Some of the other side effects associated with Xarelto include:
- Intestinal Bleeding;
- Brain Hemorrhages
- Serious Bleding
- Easy Bruisin
- Persistent Nosebleeds
- Severe Headache
- Bloody/Tarry/Black Stools
- Difficulty swallowing
The drug is touted by Johnson & Johnson and Bayer as more safe and convenient than the other blood thinners on the market. However, they seem to leave out of their marketing campaign that the drug has an extremely dangerous downside: Xarelto has no known antidote, while other anticoagulants such as warfin can be countered with vitamin K to stop the bleeding. While all blood thinners come with the risk of bleeding, the lack of an antidote means the uncontrolled bleeding can be fatal.
Minor injuries may result in major complications if the victim is taking Xarelto. Xarelto will prevent blood clotting throughout the body for periods of up to 24 hours before leaving the blood system. This places those with even a minor injury at the risk of uncontrolled bleeding for long periods of time.
Throughout the United States, you may report side effects to the Food and Drug Administration by calling (800) FDA-1088.
FDA is Receiving Hundreds of Injury Reports Linked to Xarelto
Within one year of Xarelto’s introduction to the market place, the FDA received over 350 reports of serious injuries and deaths associated with the drug. The most common report was from those suffering a pulmonary embolism after surgery while taking the blood thinner.
In early 2014, the FDA declined to allow Xarelto to be used for wider purposes as requested by Bayer and Johnson & Johnson. These companies asked the Food and Drug Administration if they could market their ‘blockbuster’ drug for prevention of clogging of heart stents, new strokes and/or hard attacks, in addition to death prevention for those suffering from acute coronary syndrome (ACS). It should be noted that ACS is really just a blanket term which covers any condition caused by sudden blood flow reduction to the heart (ex. chest pain and heart attack). If approved, the profits from the drug would have skyrocketed, as the drug could be prescribed to millions more people across the world.
It is important to note that the FDA does not conduct their own independent testing of a drug when it is submitted for approval to the FDA. The FDA simply reviews submitted testing. In 2011, Johnson & Johnson first requested wider application of the drug Xarelto. However, the FDA declined the application because there was missing data. J&J later ‘found’ some of the data and resubmitted again. However, the FDA again came back and reported that the additional data failed to show the benefits of the drug outweighed the risks. The FDA updates on Xarelto are ongoing and numerous.
Why are Xarelto Lawsuits Being Filed?
Johnson & Johnson and Bayer are facing numerous lawsuits for the intestinal bleeding and cerebral hemorrhaging of Xarelto users. The victims claim that there is no way to reverse the blood thinning effects of Xarelto if an emergency arises, and the drug therefore places consumers at unnecessary risk of serious injury and death. Other blood thinners on the market come with the important safety mechanism of a known reversal for emergency situations.
Those who are seeking reimbursement for their Xarelto related injuries have alleged specifically:
- The makers of Xarelto failed to inform doctors on how to stabilize victims if a bleed occurs
- Xarelto’s manufacturers did not warn patients of the known risks of suffering a life-threatening bleed while taking the blood thinner
- That the drug was marketed as being safer than other blood thinners on the market, despite the manufacturers knowledge that those taking Xarelto had higher rates of uncontrolled bleeding than those taking other anticoagulants such as warfin.
- Despite other known safer blood thinners, the makers of Xarelto continued to market their product in the name of profits.
If you or a loved one has suffered from uncontrolled bleeding, organ damage, or brain hemorrhages while taking Xarelto, you may be entitled to reimbursement for your harms and losses. These multinational corporations are not allowed to knowingly place unsuspecting consumers in harms way in the name of profits.
A top 100 Trial Lawyer is standing by to discuss your Xarelto or Pradaxa claim. Call us today for FREE to discuss your case. There is NO FEE for our services unless we win. We are here to help by calling 855-55-BAD-DRUG